Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer. | Front Oncol | 2021 | 34868963 | PubTator, text mining | PubMed |
| Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas. | Front Cell Dev Biol | 2021 | 34858984 | PubTator, text mining | PubMed |
| Key Markers Involved in the Anticolon Cancer Response of CD8+ T Cells through the Regulation of Cholesterol Metabolism. | J Oncol | 2021 | 34858500 | PubTator, text mining | PubMed |
| Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. | Sci Rep | 2021 | 34857786 | PubTator, text mining | PubMed |
| High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma. | Acta Derm Venereol | 2021 | 34853863 | PubTator, text mining | PubMed |
| Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC. | J Hepatocell Carcinoma | 2021 | 34849372 | PubTator, text mining | PubMed |
| Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence. | J Pers Med | 2021 | 34834481 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9. | Int J Mol Sci | 2021 | 34830271 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. | Cell Death Dis | 2021 | 34815392 | PubTator, text mining | PubMed |
| Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer. | Front Cell Dev Biol | 2021 | 34805135 | PubTator, text mining | PubMed |
| Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer. | Front Oncol | 2021 | 34804966 | PubTator, text mining | PubMed |
| Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma. | Front Oncol | 2021 | 34804925 | PubTator, text mining | PubMed |
| Genetic Analyses of Common Infections in the Avon Longitudinal Study of Parents and Children Cohort. | Front Immunol | 2021 | 34804013 | PubTator, text mining | PubMed |
| ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer. | Pharmgenomics Pers Med | 2021 | 34785930 | PubTator, text mining | PubMed |
| Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis. | Elife | 2021 | 34783307 | PubTator, text mining | PubMed |
| Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins. | PLoS One | 2021 | 34780495 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma. | Int J Environ Res Public Health | 2021 | 34769557 | PubTator, text mining | PubMed |
| Contribution of Dysregulated DNA Methylation to Autoimmunity. | Int J Mol Sci | 2021 | 34769338 | PubTator, text mining | PubMed |
| Structural variants in the Chinese population and their impact on phenotypes, diseases and population adaptation. | Nat Commun | 2021 | 34764282 | PubTator, text mining | PubMed |
| The Transcriptome Characteristics of Severe Asthma From the Prospect of Co-Expressed Gene Modules. | Front Genet | 2021 | 34759961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=55